Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function

BACKGROUND: Robotic stereotactic ablative radiotherapy (SABR) is currently under investigation as a noninvasive treatment option for patients with renal cell carcinoma (RCC). For radiation therapy of RCC, tumor motion and the need for high ablative doses while preserving the remaining renal parenchy...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Urol
Päätekijät: Senger, C., Conti, A., Kluge, A., Pasemann, D., Kufeld, M., Acker, G., Lukas, M., Grün, A., Kalinauskaite, G., Budach, V., Waiser, J., Stromberger, C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6805546/
https://ncbi.nlm.nih.gov/pubmed/31638979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-019-0531-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia